Invasive FoxM1 phosphorylated by PLK1 induces the polarization of tumor-associated macrophages to promote immune escape and metastasis, amplified by IFITM1

• Published in: Journal of experimental & clinical cancer research Vol. 42; no. 1; pp. 1 - 302
• Main Authors: Xu, Rong, Lee, Young-Joo, Kim, Chang-Hyeon, Min, Ga-Hong, Kim, Yeo-Bin, Park, Jung-Won, Kim, Dae-Hoon, Kim, Jung-Hyun, Yim, Hyungshin
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 16-11-2023; BioMed Central; BMC
• Subjects: Acids; Antibodies; Biotechnology; Cancer; Chromatin; DNA microarrays; FoxM1; Health aspects; Immunohistochemistry; Immunotherapy; Infrared imaging systems; Invasiveness; Kinases; Laboratories; Macrophages; Metastasis; Penicillin; Peptides; Phosphorylation; PLK1; Proteins; Scientific equipment and supplies industry; Stem cells; Tumor-associated macrophages; Tumorigenesis; Vascular endothelial growth factor; United States; South Korea; United States > US
• ISSN: 1756-9966; 0392-9078; 1756-9966
• DOI: 10.1186/s13046-023-02872-1

Background Understanding the mechanism behind immune cell plasticity in cancer metastasis is crucial for identifying key regulators. Previously we found that mitotic factors regulate epithelial-mesenchymal transition, but how these factors convert to metastatic players in the tumor microenvironment (TME) is not fully understood. Methods The clinical importance of mitotic factors was analyzed by heatmap analysis, a KM plot, and immunohistochemistry in lung adenocarcinoma (LUAD) patients. Immunoprecipitation, LC-MS/MS, kinase assay, and site-directed mutagenesis were performed for the interaction and phosphorylation. A tail-vein injection mouse model, Transwell-based 3D culture, microarray analysis, coculture with monocytes, and chromatin immunoprecipitation assays were used to elucidate the function of phosphorylated FoxM1 in metastasis of TME. Results The phosphorylated FoxM1 at Ser25 by PLK1 acquires the reprogramming ability to stimulate the invasive traits in cancer and influence immune cell plasticity. This invasive form of p-FoxM1 upregulates the expression of IL1A/1B, VEGFA, and IL6 by direct activation, recruiting monocytes and promoting the polarization of M2d-like tumor-associated macrophages (TAMs). Upregulation of PD-L1 in LUAD having phosphomimetic FoxM1 facilitates immune evasion. In invasive LUAD with phosphomimetic FoxM1, IFITM1 is the most highly expressed through the activation of the STING-TBK1-IRF3 signaling, which enhances FoxM1-mediated signaling. Clinically, higher expression of FOXM1, PLK1, and IFITM1 is inversely correlated with the survival rate of advanced LUAD patients, providing a promising therapeutic strategy for the treatment of LUAD. Conclusion FoxM1-based therapy would be a potential therapeutic strategy for LUAD to reduce TAM polarization, immune escape, and metastasis, since FoxM1 functions as a genetic reprogramming factor reinforcing LUAD malignancy in the TME. Keywords: FoxM1, Phosphorylation, PLK1, Invasiveness, Tumor-associated macrophages